ZP
GRCL

Zimmer Partners’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Zimmer Partners’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-70,000
Closed -$910K – 201
2021
Q2 		$910K Hold
70,000
– – 0.01% 154
2021
Q1 		$1.08M Buy
+70,000
New +$1.65M 0.01% 142

Other funds holding GRCL

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Zimmer Partners's GRCL Position: Q3 2021 in Review

Zimmer Partners sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q3 2021, closing a stake of 70,000 shares — an estimated $910K sold.

Zimmer Partners first reported a position in GRCL in Q1 2021 and held it in 2 quarters. The position peaked at $1.08M in Q1 2021. 34 funds tracked by Wall St. Rank hold GRCL as of Q3 2021.

  • Zimmer Partners reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Zimmer Partners sold 70,000 Gracell Biotechnologies Inc. American Depositary Shares shares in Q3 2021, an estimated $910K.
  • Zimmer Partners first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q1 2021 and held it in 2 quarters.
  • Zimmer Partners's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $1.08M in Q1 2021.
  • 34 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q3 2021.

Based on Zimmer Partners's 13F filing for Q3 2021, filed 15 Nov 2021.